ARBs and Myocardial Infarction.
A recent editorial in the British Journal suggested that ARBs used for treatment of hypertension may increase the risk of myocardial infarction.
D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects*; D000806:Angiotensin-Converting Enzyme Inhibitors; D018849:Controlled Clinical Trials as Topic / Q000592:standards; D006973:Hypertension; D009203:Myocardial Infarction / Q000139:chemically induced* / Q000453:epidemiology; D044140:Receptor, Angiotensin, Type 1; D012307:Risk Factors
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D044140:Receptor, Angiotensin, Type 1